 |
 |
> Dear Allstaters, > > please find attached the latest contract vacancy for you to review; > > TITLE: SAS Programmer - Phase I-II Clinical Trials > > DESCRIPTION: Essential; 3 years minimum SAS programming within the > pharmaceutical / CRO industries, SAS/base, SAS/macro & a good > understanding of data managment processes. Working for this major > pharmaceutical client you will be responsible for the SAS programming of > derived datasets, listings & figures. Your duties include; reviewing > protocols / CRFs / reporting & analysis plans, reporting of datasets, > support CDM activities, develop / test SAS programs, produce tables / > summaries / listings & work closely with CROs in reporting activities. > > START DATE: ASAP, but they will wait for notice period. > LOCATION: UK based role, in the South East > RATE: Dependant on experience > CONTRACT LENGTH: 12 months+ > > If you are interested in this role please get in contact ASAP for more > details. > > Regards > > James Carrera > European Contracts Manager > Pharmaceutical, Healthcare & CRO division. > 1st IT People > Tel: +44 (0) 207 940 3900 > Fax: +44 (0) 207 886 8161 > mailto:[log in to unmask] > www.1st-itpeople.com > > Offices in UK, Switzerland, The Netherlands & Hong Kong > This email is confidential and intended solely for the use of the > individual to whom it is addressed. Any views or opinions presented are > solely those of the author and do not represent those of the company from > which the email was sent. If you are not the intended recipient, be > advised that you have received this e-mail in error and that any use, > dissemination forwarding, printing or copying of this e-mail is strictly > prohibited. While every effort has been made to scan this e-mail, we can > not accept any responsibility for loss of business or damage caused > arising from this e-mail. > This email is confidential and intended solely for the use of the individual to whom it is addressed. Any views or opinions presented are solely those of the author and do not represent those of the company from which the email was sent. If you are not the intended recipient, be advised that you have received this e-mail in error and that any use, dissemination forwarding, printing or copying of this e-mail is strictly prohibited. While every effort has been made to scan this e-mail, we can not accept any responsibility for loss of business or damage caused arising from this e-mail.